ITCM is a global manufacturer and leading innovator in customised machinery and systems for pharmaceutical packaging and processing.

 

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that the Thermo Scientific Varioskan Flash spectral scanning multimode reader has been certified for use with LanthaScreen® assays, from Invitrogen, a division of Life Technologies Corporation. The LanthaScreen assay is an advanced time-resolved fluorescence energy transfer (TR-FRET) technology for drug discovery applications. Using the time-resolved fluorescence (TRF) technology of the Varioskan® Flash, biological background interference is minimized, improving sensitivity in cellular assays. The flexibility of the Varioskan Flash, in combination with the LanthaScreen platform enables rapid application of TR-FRET technology to multiple target classes across a wide range of application areas, such as second messenger, kinase or hormone receptor assays.

The Thermo Scientific Varioskan Flash provides accurate fluorescence cell-based assay results due its advanced features, such as the automatic instrument calibration system, combined with automatic measurement control and diagnostics. The easy-to-use multiwavelength measurement feature makes it possible to accurately measure donor and acceptor emissions in a simple and time-efficient manner. Furthermore, these assays can be precisely performed using low volume 384-well plates, making the combination of the Varioskan Flash and LanthaScreen especially useful for screening purposes where low sample consumption is important.

The Varioskan Flash multimode reader provides high-quality data with low background fluorescence, enabling accurate results to be obtained with LanthaScreen TR-FRET assay technology from Invitrogen. For any additional information please visit www.thermo.com/readingroom.

Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.

LanthaScreen is a registered trademark of Invitrogen, a division of Life Technologies Corporation.